Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl4

World Journal of Gastroenterology

Volumn 6, Issue 4, 2000, Pages 540-545

  Wei, H S ^a   Li, D G ^a   Lu, H M ^a   Zhan, Y T ^a   Wang, Z R ^a   Huang, X ^a   Zhang, J ^a   Cheng, J L ^a   Xu, Q F ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARBON TETRACHLORIDE; HYALURONIC ACID; LOSARTAN; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG INHIBITION; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 0033847889     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-α1 and traditional medicine preparation
2. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B
3. Fat-storing cells and liver fibrosis
4. Study of heteroserum-induced rat liver fibrosis model and its mechanism
5. 4 D-Gal and ANIT in mice
6. Cellular immune function and liver damage in post-hepatitic cirrhosis
7. Study on the role of free fatty acids in proliferation of rat hepatic stellate cells (II)
8. Effect of lipid on proliferation and activation of rat hepatic stellate cells (I)
9. Progress in studies of tetrandrine against hepatofibrosis
10. Effect of amygdalin on proliferation of rat hepatic fat-storing cells and collagen production in vitro
11. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis
12. The effect of retinoic acid on Ito cell proliferation and content of DNA and RNA
13. Role of transforming growth factor beta type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats
14. Transforming growth factor-β signaling and cirrhosis
15. Fibrodynamics - Elucidation of the mechanisms and sites of liver fibrogenesis
16. Therapeutic effect of Zijin capsule in liver fibrosis in rats
17. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells
18. 4-induced injury to primarily cultured rat hepatocytes
19. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats
20. Experimental study of bioartificial liver with cultured human liver cells
21. Angiotensin-converting enzyme inhibitors: Congestive heart failure and beyond
22. Cardioprotective effect angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes
23. Captopril inhibits apoptosis in human lung epithelial cells: A potential antifibrotic mechanism
24. The renin-agiotensin system and compensatory renal hypertrophy in the rat
25. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension
26. Angiotensin converting enzyme inhibitors: First line therapy in patients with diabetic hypertension?
27. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor antagonist and role in cardiac fibrosis
28. Effects of losartan and captopril on expression of cardiac angiotensin AT1 receptor mRNA in rats following myocardial infarction
29. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
30. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts
31. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart
32. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts
33. Effect of AT2 receptor antagonist on the pathogenesis of renal fibrosis
34. Cardiac interstitial fluid levels of angiotensin I and II in the pig
35. Increased expression of glomerular AT1 receptors in rats with myocardial infarction
36. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes
37. Role of the renin-angiotensin system in cardiac hypertrophy
38. Progression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats
39. Inhibitory effects of captopril on hypoxia-induced proliferation and collagen synthesis in pulmonary vascular smooth muscule cells
40. Role of AT1 angiotensin II receptors in renal ischemic injury
41. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: Beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA
42. Angiotensin II receptor blockers
43. Angotensin II -induced modulation of rat mesangial cell phenotype
44. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis
45. Antesin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis
46. Angiotensin II antagonist decreases TGF-β and matrix protein in cyclosporine nephropathy
47. Angiotensin-converting enzyme inhibition by enalapril: A novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation
48. The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions
49. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblasts
50. Gene therapy by transforming growth factor-β receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis